WHO recommendations on uterotonics for postpartum haemorrhage prevention: what works, and which one?
Saved in:
| Main Authors: | Joshua P Vogel, Myfanwy Williams, Ioannis Gallos, Fernando Althabe, Olufemi T Oladapo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-03-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/4/2/e001466.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research agenda for ending preventable maternal deaths from postpartum haemorrhage: a WHO research prioritisation exercise
by: Fernando Althabe, et al.
Published: (2024-11-01) -
Healthcare providers experiences of using uterine balloon tamponade (UBT) devices for the treatment of post-partum haemorrhage: A meta-synthesis of qualitative studies.
by: Kenneth Finlayson, et al.
Published: (2021-01-01) -
Modelling the economic impact of substandard uterotonics on postpartum haemorrhage in Nigeria: safeguarding medicine quality can reduce costs and contribute towards universal health coverage
by: Ahmet Metin Gülmezoglu, et al.
Published: (2025-05-01) -
Cost-effectiveness results comparing heat-stable carbetocin & other uterotonics in postpartum heamorrhage prevention in Uganda.
by: Sam Ononge, et al.
Published: (2025-01-01) -
Pharmacological Management of Postpartum Haemorrhage
by: A. V. Rostovtsev, et al.
Published: (2022-12-01)